Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
Biostem Technologies Inc BSEM
$4.14
▲ +6.70%
(+$0.26)
⬆️ Above Yest. High
Open
$3.85
Prev Close
$3.88
Day Range
$3.81 – $4.28
52W Range
$2.25 – $8.40
Market Cap
$73.83M
Beta
0.54
EPS (TTM)
$-1.20
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | OTC MARKETS |
| Currency | USD |
| IPO Date | 2001-07-11 |
| Shares Out. | 16,980,000 |
| Website | biostemtechnologies.com/ ↗ |
| Phone | 19543808342 |
| Employees | 2 |
About Biostem Technologies Inc
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
Biostem Technologies Inc is a publicly traded company under the ticker symbol BSEM on the OTC MARKETS, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-09-01)